References
- Cousins MJ, Brennan F, Carr DB. Pain relief: a universal human right. Pain 2004; 112: 1-4. https://doi.org/10.1016/j.pain.2004.09.002
- Bolash R, Udeh B, Saweris Y, Guirguis M, Dalton JE, Makarova N, et al. Longevity and cost of implantable intrathecal drug delivery systems for chronic pain management: a retrospective analysis of 365 patients. Neuromodulation 2015; 18: 150-5. https://doi.org/10.1111/ner.12235
- Goldberg DS, McGee SJ. Pain as a global public health priority. BMC Public Health 2011; 11: 770. https://doi.org/10.1186/1471-2458-11-770
- Breivik H, Eisenberg E, O'Brien T; OPENMinds. The individual and societal burden of chronic pain in Europe: the case for strategic prioritisation and action to improve knowledge and availability of appropriate care. BMC Public Health 2013; 13: 1229. https://doi.org/10.1186/1471-2458-13-1229
- Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 2006; 10: 287-333. https://doi.org/10.1016/j.ejpain.2005.06.009
- Smith BH, Torrance N. Management of chronic pain in primary care. Curr Opin Support Palliat Care 2011; 5: 137-42. https://doi.org/10.1097/SPC.0b013e328345a3ec
- Moore RA, McQuay HJ. Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioids. Arthritis Res Ther 2005; 7: R1046-51. https://doi.org/10.1186/ar1782
- Wallace M, Yaksh TL. Long-term spinal analgesic delivery: a review of the preclinical and clinical literature. Reg Anesth Pain Med 2000; 25: 117-57.
- Anderson VC, Burchiel KJ. A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain. Neurosurgery 1999; 44: 289-300. https://doi.org/10.1097/00006123-199902000-00026
- Paice JA, Winkelmuller W, Burchiel K, Racz GB, Prager JP. Clinical realities and economic considerations: efficacy of intrathecal pain therapy. J Pain Symptom Manage 1997; 14: S14-26. https://doi.org/10.1016/S0885-3924(97)00167-X
- Deer TR, Krames E, Levy RM, Hassenbusch SJ 3rd, Prager JP. Practice choices and challenges in the current intrathecal therapy environment: an online survey. Pain Med 2009; 10: 304-9. https://doi.org/10.1111/j.1526-4637.2009.00568.x
- Kim EJ, Moon JY, Kim YC, Park KS, Yoo YJ. Intrathecal morphine infusion therapy in management of chronic pain: present and future implementation in Korea. Yonsei Med J 2016; 57: 475-81. https://doi.org/10.3349/ymj.2016.57.2.475
- The Korean Pain Society. Textbook of pain medicine. 4th ed. Seoul, Shinwon Medical. 2012, pp 469-80.
- Tracey I, Bushnell MC. How neuroimaging studies have challenged us to rethink: is chronic pain a disease? J Pain 2009; 10: 1113-20. https://doi.org/10.1016/j.jpain.2009.09.001
- Hamza M, Doleys D, Wells M, Weisbein J, Hoff J, Martin M, et al. Prospective study of 3-year follow-up of low-dose intrathecal opioids in the management of chronic nonmalignant pain. Pain Med 2012; 13: 1304-13. https://doi.org/10.1111/j.1526-4637.2012.01451.x
- Auld AW, Maki-Jokela A, Murdoch DM. Intraspinal narcotic analgesia in the treatment of chronic pain. Spine (Phila Pa 1976) 1985; 10: 777-81. https://doi.org/10.1097/00007632-198510000-00014
- Turner JA, Sears JM, Loeser JD. Programmable intrathecal opioid delivery systems for chronic noncancer pain: a systematic review of effectiveness and complications. Clin J Pain 2007; 23: 180-95. https://doi.org/10.1097/01.ajp.0000210955.93878.44
- Duarte RV, Raphael JH, Haque MS, Southall JL, Ashford RL. A predictive model for intrathecal opioid dose escalation for chronic non-cancer pain. Pain Physician 2012; 15: 363-9.
- Atli A, Theodore BR, Turk DC, Loeser JD. Intrathecal opioid therapy for chronic nonmalignant pain: a retrospective cohort study with 3-year follow-up. Pain Med 2010; 11: 1010-6. https://doi.org/10.1111/j.1526-4637.2010.00876.x
- Kumar K, Kelly M, Pirlot T. Continuous intrathecal morphine treatment for chronic pain of nonmalignant etiology: long-term benefits and efficacy. Surg Neurol 2001; 55: 79-86. https://doi.org/10.1016/S0090-3019(01)00353-6
- Grider JS, Harned ME, Etscheidt MA. Patient selection and outcomes using a low-dose intrathecal opioid trialing method for chronic nonmalignant pain. Pain Physician 2011; 14: 343-51.
- Konrad PE, Huffman JM, Stearns LM, Plunkett RJ, Grigsby EJ, Stromberg EK, et al. Intrathecal drug delivery systems (IDDS): the implantable systems performance registry (ISPR). Neuromodulation 2016; 19: 848-56. https://doi.org/10.1111/ner.12524
- Mueller-Schwefe G, Hassenbusch SJ, Reig E. Cost effectiveness of intrathecal therapy for pain. Neuromodulation 1999; 2: 77-87.